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Abstract A novel antigen recognized by serum from a 
scleroderma patient was identified by expression cloning from 
the HeLa cell cDNA library. The cloned cDNA encoded a 374-
amino acid protein with a relative molecular mass of 47 000 and a 
predicted amino acid sequence 62.7% identical to the hypothe-
tical protein of Caenorhabditis elegans, T16H12.5. The deduced 
amino acid sequence had a typical P O Z domain and an 
unidentified region conserved during evolution. No zinc finger 
or RNA recognition motifs were found in this clone. The 2 kbp 
mRNA encoding the novel clone S P O P (speckle-type P O Z 
protein) was found to be expressed in all human tissues 
examined. HA-tagged SPOP, transfected and overexpressed in 
COS7 cells, exhibited a discrete speckled pattern in the nuclei 
and was co-localized with the splicing factor, snRNP B7B. 
Deletion analysis revealed that both the POZ domain and the 
evolutionarily conserved region at the amino-terminus are 
required for the nuclear speckled accumulation of SPOP. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
H u m a n autoantibodies have proven to be useful reagents 
for identifying novel nuclear antigens. Several autoantibodies 
are known to recognize proteins which are highly conserved in 
evolution and are involved in essential intracellular functions 
such as D N A replication, transcription, and splicing of pre-
m R N A [1]. In a previous study, we isolated c D N A clones 
encoding transcription factor Z F 5 [2], which is present in 
speckle structures, and a novel M A P kinase kinase (MKK6) 
[3] from a HeLa c D N A library using autoantibodies. In the 
present study, a novel human c D N A was isolated by this 
immunoscreening approach with serum from a scleroderma 
patient and designated SPOP (speckle-type P O Z protein). 
2. Materials and methods 
2.1. cDNA cloning and sequence analysis of SPOP 
Patient K.M. had a scleroderma disease and her antiserum (#232) 
reacted with nuclear proteins of HEp-2 cells and showed a typical 
coarse speckled pattern. To identify the nuclear antigen, the #232 
serum was used for immunoscreening of 5X105 recombinants from 
a HeLa Uni-ZAP XR cDNA library (Stratagene) as previously de-
scribed [3]. pBluescript SK~ plasmid clones containing cDNA inserts 
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were isolated by in vivo excision as recommended by the manufac-
turer (Stratagene). The cDNA clones were sequenced on both strands 
by primer walking using Dye Deoxy terminators (Applied Biosystems) 
and an ABI 373A DNA sequencer (Applied Biosystems). We desig-
nated one clone containing the full length coding region pBS6111. 
2.2. Northern blot analysis 
A human multiple tissue blot containing approximately 2 ug of 
poly(A)+ RNA per lane from eight different human tissues (Clontech) 
was hybridized with the 32P-labeled 1.5 kbp cDNA probe in Express-
Hyb solution (Clontech) according to the manufacturer's instructions. 
2.3. Plasmid constructs 
HA-tagged SPOP with the entire protein coding region (wild-type) 
was constructed by the polymerase chain reaction (PCR). A 24-base 
synthetic single-stranded DNA PCR primer, 5'-A (GTCGACATGT-
CAAGGGTTCCAAGT), and a 3'-A primer (GCGGCCGCAC-
GACTCACTATAGGGC) were used to prime a PCR with pBS6111 
as the template DNA. The amplified fragment was digested with Sail 
and Not! and ligated into the linearized pME-HA vector [3], resulting 
in the pME-HA-SPOP plasmid. Deletion mutants of SPOP were also 
generated by PCR. For HA-SPOP (A71-374) and HA-SPOP (A192-
374), PCR fragments were amplified with the 5'-A primer as the 
antisense primer and 3'-B (GCGGCCGCTCGCAAACACCATTT-
CA) or 3'-C (GCGGCCGCTCCTAACTCATCTGCCAG). HA-
SPOP (Al—185) was also constructed as described above with 5'-B 
(GTCGACCTGGCAGATGAGTTAGGAG) as the sense primer. 
2.4. Cell culture and immunofiuorescence 
Monkey kidney COS7 cells were grown in Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% FCS on glass cov-
erslips in 24-well dishes and transfected with 2 ug aliquots of plasmid 
DNA in DEAE-dextran. After 36^18 h, cells were fixed with 3.5% 
paraformaldehyde in PBS for 5 min and then permeabilized in 0.1% 
Triton X-100/PBS solution. Anti-HA tag staining was performed by 
incubation for 1 h at room temperature with 12CA5 anti-HA mono-
clonal antibody 1:1000 diluted in PBS with 1% BSA. Cells were then 
washed twice with PBS and incubated for 1 h at room temperature 
with 1:50 fluorescein-conjugated anti-mouse IgG antibody. Intracel-
lular localization of antigens was analyzed by MRC 1024 confocal 
microscopy (Bio-Rad). 
2.5. Western blotting and immunoprecipitation 
COS7 cells were transfected with 10 ug plasmid DNA per 6-well 
dish as described above, harvested 48 h thereafter by scraping into ice-
cold NET-2 (150 mM NaCl, 50 mM Tris-Cl, pH 7.5, 0.05% NP-40, 
and 1 mM PMSF) and disrupted by sonication. Total cell extracts 
were precleared with protein G-Sepharose beads (Pharmacia) for 60 
min at 4°C. 
Immunoprecipitation was performed with protein G-Sepharose 
antibodies in NET-2 for 60 min at 4°C followed by washing four 
times with NET-2. Samples were separated on 15% SDS-polyacryl-
amide gels and electrotransferred to nitrocellulose membranes (Hy-
bond C, Amersham). After blocking with 10% dried milk powder in 
TBS-T (20 mM Tris-Cl, 137 mM NaCl, and 0.1% Tween-20) for 60 
min and incubation with 12CA5 monoclonal antibody for another 60 
min at room temperature, the membranes were washed and incubated 
with the secondary antibody (goat anti-mouse IgG, HRP conjugated 
[Amersham]) for 60 min at room temperature. Detection was per-
formed by ECL (Amersham) with X-ray films exposed for 1-15 min. 
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Fig. 1. Subcellular location of SPOP. A: Immunofluorescence staining of COS7 cells with autoimmune serum #232 taken from a scleroderma 
patient. B: Localization of HA-tagged SPOP recombinant protein. COS7 cells were transfected with HA-tagged SPOP expression vector, incu-
bated with 12CA5 anti-HA antibody and then observed under the confocal microscope. C: Immunoblotting of HA-tagged SPOP expressed in 
COS7 cells. The total cell extract from the COS7 cells transiently expressing HA-SPOP was resolved by 10% SDS-PAGE and processed for im-
munoblotting with 12CA5 antibody. 
3. Results 
Immunostaining of COS7 cells with the antiserum (#232) 
from the scleroderma patient resulted in a rough speckled 
pattern in nuclei (Fig. 1A). As this serum #232 did not react 
with known spliceosomal antigens such as Sm, SS-A, and SS-
B (data not shown), we started an immunoscreening of a 
human HeLa cell cDNA library to identify the antigen. Ap-
proximately 5 x l 0 5 phage plaques were screened, and five 
positive clones were isolated. One clone, designated clone 
6111, carried a 1.6-kbp insert containing an open reading 
frame which encodes a protein of 374 amino acids. The ini-
tiation codon was found 33 bp downstream of the in-frame 
stop codon and no polyadenylation signal was observed. The 
HA-tagged recombinant protein expressed in COS7 cells had 
a relative molecular mass of 47000 (Fig. 1C) and showed a 
discrete speckled pattern in the nuclei (Fig. IB). 
A BLAST search of GenBank suggested that the cDNA 
encodes a novel protein which has the POZ (poxvirus and 
zinc finger) domain [4], but no other functional domains 
such as the zinc finger or the RNA recognition motif (Fig. 
2B). The protein, designated speckle-type POZ protein 
(SPOP), is 62.7% identical to a hypothetical protein, 
T16H12.5, in Caenorhabditis elegans which is also a member 
of the POZ family (Fig. 2A). In addition to the POZ domain, 
we found that the amino-terminus of SPOP (amino acids 17-
151) is highly conserved between SPOP and the T16H12.5 
protein (91% identity), and named the domain the NS (N-
terminus of SPOP) domain (Fig. 2B). Northern blot analysis 
of poly(A)+ RNA from human tissues revealed the ubiquitous 
presence of a 2.0 kbp long SPOP mRNA in all tissues exam-
ined (Fig. 3). 
To examine whether the intranuclear localization of SPOP 
is identical to that of spliceosomes, co-localization between 
SPOP and snRNP B7B was analyzed. The nuclear speckles 
of SPOP recognized by anti-HA monoclonal antibody in the 
transfected COS7 cells were also stained with an affinity-pu-
rified autoimmune antiserum to snRNP B7B, although diffuse 
background staining was present in this case (Fig. 4). As 
SPOP lacks any of the consensus sequences observed in 
many spliceosomal proteins such as the arginine-serine (RS) 
domain and the RNA recognition motifs (RRM), it may be 
deduced that it associates with other spliceosomal proteins 
which have signals required for nuclear speckled localization. 
In an attempt to identify the partner for SPOP in splice-
osomes, we carried out co-immunoprecipitation studies of 
HA-tagged SPOP transfected in COS7 cells with several auto-
immune sera under low-salt conditions preserving protein-
protein interactions. However, no positive band was obtained 
from precipitates with anti-snRNP B7B or anti-snRNP-70 
antisera (data not shown). 
To identify the domain required for intranuclear speckled 
localization of SPOP, several deletion mutants of SPOP were 
constructed and expressed in COS7 cells. The structures of the 
mutant SPOP proteins are shown in Fig. 5A. Immunofluo-
rescence studies were performed with anti-HA antibody with 
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Fig. 2. Structure of human SPOP. A: The amino acid sequence 
alignment of SPOP and T16H12.5. The positions of identical amino 
acids in these two proteins are indicated by asterisks. Gaps (-) were 
introduced to optimize the alignment. B: Schematic representation 
of the SPOP cDNA is shown with the coding region indicated by 
the outlined box. The N-terminus of SPOP (NS) domain with the 
N-terminal side of C. elegans hypothetical protein T16H12.5, and 
the POZ domain (POZ) are shown by dotted and solid boxes, re-
spectively. The numbers above the boxes indicate the positions of 
amino acids. 
Y. Nagai et al.lFEBS Letters 418 (1997) 23-26 25 
Fig. 3. Northern blot analysis of human tissues with the SPOP 
cDNA probe (upper panel). The blot was subsequently stripped and 
rehybridized with (3-actin control probe (lower panel). 
COS7 cells, 48 h after transfection of the mutant vectors. In 
contrast to the nuclear speckled localization of full-length 
SPOP (Fig. 5B), SPOP (A71-374) produced a speckled ap-
pearance throughout the entire cytoplasm without nuclear 
staining (Fig. 5C). SPOP (A192-374) showed a diffuse nuclear 
pattern suggesting the presence of a nuclear localization signal 
(NLS) in amino acids 71-191 of SPOP, though no known 
NLS consensus was found to be included. The N-terminal 
deletion of SPOP (Al—185) resulted in a minute speckled local-
ization in the nucleus which was distinct from the more dis-
crete speckled pattern observed on the wild-type SPOP (Fig. 
5D). Thus at least two distinct protein-protein interaction 
domains of SPOP may determine the intracellular localization 
of the protein. The C-terminal peptide of SPOP retained im-
munoreactivity recognized by antiserum #232, while the N-
terminal peptides described above were not immunoprecipi-
tated by this serum, indicating that the epitope of SPOP for 
#232 serum is located in the C-terminal half of the protein. 
4. Discussion 
We report here the isolation of a cDNA encoding SPOP, a 
novel nuclear antigen recognized by serum from a scleroder-
ma patient. Immunoprecipitation analysis of deletion mutants 
indicated that the carboxy-terminal half of SPOP contains the 
epitope for the antibodies used for the cDNA screening. The 
protein was found to be expressed in all human tissues exam-
ined and bears high similarity at the amino acid level to a 
hypothetical protein (T16H12.5) in chromosome III of 
Fig. 4. Co-localization of SPOP with a spliceosomal protein, snRNP 
B7B. COS7 cells transfected with HA-tagged SPOP expression vec-
tor were stained with anti-Sm human antibodies affinity-purified 
from the SLE patient serum with recombinant B7B protein (A) and 
with anti-HA monoclonal antibody (B). 
Fig. 5. Schematic illustration of the SPOP deletion mutant forms 
and results for their subcellular localization. A: Schematic represen-
tation of wild-type and mutant SPOPs along with results of immu-
noprecipitation experiments using the anti-HA antibody and the 
autoimmune serum (#232) performed as described above. B: Differ-
ential localization of SPOP variants in COS7 cells transfected with 
the indicated SPOP deletion mutants. All cells are stained with the 
12CA5 antibody. 
C. elegans, with 63% identity and 82% similarity [5]. No ob-
vious function of C. elegans T16H12.5 protein has yet been 
reported. 
The POZ (for poxvirus and zinc finger) or BTB (for Broad 
Complex, tramtrack and brie a brae) [6] is a conserved and 
hydrophobic domain, composed of approximately 120 amino 
acids, and present generally at the NH2-terminal end of nu-
merous proteins. POZ proteins have been divided into three 
classes [7]. The first comprises examples interacting with DNA 
and most of these are zinc finger proteins such as Ttk, GAGA 
and ZF5, except for the Drosophila E(var)3-93D product, 
stretches of whose charged amino acids may bind to DNA. 
We recently identified a human homologue of ZF5 as an auto-
immune antigen [2]. The second class of POZ proteins in-
cludes a C. elegans protein, the Drosophila kelch gene product, 
and viral proteins from three distinct poxvirus genera. All 
these share an array of six imperfect repeats, each approxi-
mately 50 amino acids long, forming an actin-binding domain. 
The third class comprises proteins containing a POZ domain 
in the absence of any other known DNA- or protein-binding 
motifs. Although several members of this subfamily have been 
identified by genomic sequence analysis in poxviruses, C. ele-
gans and man, the functions of these genes are unknown. Our 
present data indicate that SPOP should be classified in this 
group as the human homologue of C. elegans T16H12.5. 
Conserved residues, the majority of which are hydrophobic, 
are thought to mediate protein-protein interactions. The POZ 
domain is predicted to be folded to form four cc-helices, sep-
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arated by (3-sheet structures [4]. In the present study, HA-
tagged SPOP, transfected and expressed in COS7 cells, exhib-
ited a discrete speckled pattern of nuclear distribution, co-
localizing with a splicing factor, snRNP B7B. As SPOP has 
no RRM, it is conceivable that it may be anchored to the 
spliceosome by protein-protein interactions with some splice-
osomal factor(s) through its POZ domain located within ami-
no acids 190-289. Thus, a deletion mutant lacking the POZ 
domain was found to be diffusely localized throughout the 
nucleus. In addition to the POZ domain, the NS domain is 
surprisingly conserved between SPOP and T16H12.5 protein 
in C. elegans (91% identity). Deletion of this region also re-
sulted in the loss of speckled localization. These data indicate 
that either the amino- or the carboxy-terminal half is sufficient 
for nuclear localization of SPOP, but that both of them are 
required for aggregation at spliceosomal sites. The staining 
pattern of nuclear speckles in COS7 cells with the patient 
serum was not identical to that of HA-tagged SPOP, suggest-
ing the existence of other major antigen(s) in the autoimmune 
serum. Actually four other distinct clones were isolated which 
were all immunopositive with the serum but did not overlap 
with any part of SPOP (data not shown). 
Recent findings have suggested that C. elegans gene mel-26, 
which is closely related to T16H12.5, acts as a post-meiotic 
negative regulator of mel-1, an oocyte meiosis-specific gene 
[8]. The phenotype of T16H12.5 loss-of-function C. elegans 
mutants should now be analyzed to provide clues to the phys-
iological function of SPOP. 
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